Presence | AI Transformation Index

Presence occupies a structurally defensible niche — IDEA-mandated special education therapy delivered by licensed clinicians — that AI cannot substitute aw...

PresenceHealthcare (Medical - Equipment & Services)TPG

Overview

Presence (PresenceLearning) delivers remote speech-language, occupational, mental health, and behavioral therapy services to K-12 schools through a proprietary teletherapy platform, monetizing via subscription contracts with school districts that need clinician access to meet special education compliance mandates.

Executive Summary

Presence occupies a structurally defensible niche — IDEA-mandated special education therapy delivered by licensed clinicians — that AI cannot substitute away in the near term, giving the business durable demand; the risk is not demand disappearance but competitive margin compression and potential platform commoditization as AI capabilities advance. The AI opportunity is real and PE-actionable: AI-assisted documentation and IEP workflow automation could meaningfully expand clinician capacity and improve margins without requiring a change to the licensed-delivery model, and over time, capturing clinical domain intelligence at the platform level could build a genuine intelligence moat. For TPG's Rise Fund, the investment thesis should center on using AI to remove the administrative burden that limits clinician throughput — the business grows without proportional headcount growth — while the regulatory environment provides a durable runway to execute.

Durability

How resilient is this business against AI disruption?

FactorValue

Market Substitutability

6

Profit Pool Migration

5

Barrier to Entry

8

Disintermediation Exposure

6

Switching Costs

6
Total62.0
×

Opportunity

How big a deal is AI for this business?

FactorValue

AI Applicability

6

Improvement Magnitude

6

Transformation Upside

6

Domain Intelligence Amplification

6
Total60.0

61.0

Ciridae AI Score

Durability Rationale

Presence's durability is anchored by a legally non-negotiable demand driver — IDEA mandates that schools provide therapy services to eligible students, and state licensure requirements mean a human clinician must be in the loop — creating a structural floor under demand that pure AI substitution cannot eliminate in the foreseeable regulatory environment. The platform's embedded compliance workflows, district relationships, and clinician network create moderate switching costs, but the business is more exposed than a pure infrastructure play: the platform sits in a coordination layer between clinicians and districts that could be replicated, and the moderate competitive fragmentation means AI-enabled competitors could erode pricing power. The strongest durability argument is regulatory — not competitive moat depth.

Opportunity Rationale

The most compelling AI opportunity for Presence is clinician productivity amplification: licensed therapists spend a disproportionate share of their time on documentation, IEP reporting, progress notes, and administrative coordination — all highly compressible by AI — which means AI could meaningfully increase caseload capacity per clinician without adding headcount, directly improving the unit economics of the business. The domain intelligence embedded in special education therapy is real and judgment-based (intervention sequencing, IEP goal calibration, behavioral case formulation), creating genuine O4 potential if Presence can capture it at the platform level rather than leaving it in individual clinicians' heads. The transformation upside is meaningful but bounded — this is not an order-of-magnitude story because the licensed human session remains the core billable unit, but AI could enable Presence to serve 2-3x the students with the same clinical capacity.

Key Risks

The regulatory protection thesis could erode faster than expected if state-level regulatory bodies begin accepting AI-assisted or AI-delivered interventions for certain IEP service types — particularly lower-acuity speech and behavioral supports — which would rapidly expand the substitution surface and invite AI-native EdTech entrants with better technology and lower cost structures.

The AI opportunity thesis depends on Presence capturing clinical domain intelligence at the platform level, but if clinicians remain independent contractors who own their own workflows and resist AI augmentation (due to liability concerns or workflow disruption), the productivity gains may be difficult to realize at scale — leaving the opportunity on the table while a more tech-forward competitor captures it.

Company Overview

HeadquartersNew York, New York, United States
Products / Services
Teletherapy services including speech-language therapy, occupational therapy, mental health counseling, and behavioral services. Psychoeducational evaluations and assessments. A digital therapy platform that supports clinicians with scheduling, documentation, and therapy activities. Services tailored for schools, agencies, and independent practitioners. A network of over 2,000 clinicians serving more than 10,000 schools.
Deal Partners

PE / Ownership History

EventDetails
Majority Investment by Spectrum Equity and TPG's Rise Fund
January 2022
PresenceLearning also acquired Global Teletherapy in this transaction.
Blue Heron Capital Exit
Date not specified, post-2021
Blue Heron Capital exited its investment in PresenceLearning as a result of the majority investment by Spectrum Equity and TPG's Rise Fund.
$27 Million Series D Growth Investment Led by Bain Capital Double Impact
May 2020
PresenceLearning secured $27 million in Series D funding led by Bain Capital Double Impact.
Series B Funding Led by New Markets Venture Partners and Blue Heron Capital
April 2013
PresenceLearning raised $8 million in Series B funding.

Executives

NameBackground
Kate Eberle Walker
Chief Executive Officer (CEO)
Kate Eberle Walker has over 20 years of experience leading education companies. Prior to PresenceLearning (joined as CEO in 2019), she was CEO of The Princeton Review and Tutor.com. She led corporate strategy and investments for Kaplan, Inc. Early career as an investment banker at Goldman Sachs. Education: MBA from Harvard Business School, undergraduate degree from Georgetown University. Serves on education-focused boards including Babbel, Barnes and Noble Education, Prospect Schools, and Testing Mom. Author of "The Good Boss: Nine Ways Every Manager Can Support Women at Work". Based in New York, lives with her family. LinkedIn: [Kate Eberle Walker](https://www.linkedin.com/in/eberlewalker/)
Jess Compagnola
Chief Financial Officer (CFO)
Jess is a strategic financial leader with 20+ years of experience scaling high-growth companies. Previous roles include CFO of Carrum Health (digital health company) and CFO/EVP of Finance at Nomad Health, where he helped grow revenue from $6M to $550M. Experience in capital allocation, fundraising, M&A, FP&A, and team building. Started career at PwC. Education: MBA from Columbia Business School. Based in New York. LinkedIn: [Jess Compagnola](https://www.linkedin.com/in/jess-compagnola-5290649/)
Jennifer Berry
Chief Operating Officer (COO)
Joined PresenceLearning as COO to scale the company. Has a rich history in education dating back to 2009. Holds a BA in American Studies/Education from Colby College. Experienced educational professional with a background in teaching and consulting. LinkedIn: [Jennifer Berry](https://www.linkedin.com/in/dr-jennifer-berry-9a05113)
Anne Hogarty
Chief Commercial Officer (CCO)
Strategy, operations, and finance executive focused on growth and profitability for mission-driven organizations. Previously CEO of Extend Fertility, a women's healthcare company. Held executive roles at BuzzFeed, Deutsche Bank, Goldman Sachs, and Kaplan. Education: BA from Harvard College, MBA from Harvard Business School. Based in New York. LinkedIn: [Anne Hogarty](https://www.linkedin.com/in/annehogarty)
Fletcher Hutson
Chief Revenue Officer (CRO)
Over a decade of experience in sales and revenue leadership, previously at PowerSchool.
Brian Stephen
General Counsel
20+ years of legal experience in private equity and education sectors.
Colt Stander
Chief Product Officer (CPO)
15+ years building products for consumers and clinicians, with experience in health tech.